A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 5/5/2010

Posted by | 4:38pm on Wednesday, May 5, 2010

:
It’s 8 pm ET that means its time for the pharma marketing & social media chat #socpharm! Welcome & intro yourself. 5/5/2010 19:02

:
Please note we’ll assume that all tweets within #socpharm are your own and not your employers (unless you specifically declare them)

:
I’m Eileen, work at Siren Interactive on strategy/search for pharma companies who have therapies for rare diseases. #socpharm

:
Im Dan I work in the clinical trials industry from the site level and have dedicated a blog towards demystifying the topic #socpharm

:
Hello Eileen & #socpharm community, Angela Dunn here, Dir Social Media @, exec search #healthcare comm & #pharma mktg #socpharm

:
T1: Unfortunately there’s been another @ & consumers are taking to sm: http://bit.ly/bHj8RA What can McNeil do? #socpharm

:
I’m Joel, Co-Founder & CEO of @, the Trusted Physician’s Network, looking forward to another great #socpharm discussion

:
T1: Twitter acct set up to handle last recall (@McNeilRecall) has been called back into service w/links to new press release. #socpharm

:
Agree w/ @ “need 2 be honest about happened & let public know it will do everything…2 make products as safe as can be.” #socpharm

:
Hi, everyone, sorry I’m late. Heather, compliance attorney at DSI. #socpharm

:
Mark Dimor Applying principles of MD learning & med education across the evolving spectrum of medical communication and promotion #socpharm

:
@ @ – i agree, they need to be honest & transparent about what happened & how they are responding to concerns #socpharm

:
@ authenticity, honesty, and acting like human beings not a behemoth corporation will be good for J&J during this #socpharm

:
SM is only one part of a larger issue w/J&J. SM can help to pull the public into place to help manage the specifics of recall #socpharm

:
RT @: authenticity, honesty & acting like human beings….will be good 4 J&J during this #socpharm

:
T1: Amazing how consumers are so savvy today, the Ad Age article quoted guy who slammed McNeil for releasing news on Friday night #socpharm 5/5/2010 19:17

:
@ @ – J&J is often cited as a #socpharm leader & they need to be much more proactive reaching out to concerned parents 5/5/2010 19:17

:
@ Yes, agree! Consumers are getting more & more savvy. #socpharm 5/5/2010 19:18

:
Is the overall J&J plan crisis plan working here? What about the 800 number being busy? #socpharm 5/5/2010 19:19

:
@ I agree J&J is a leader with caregiver issues as well but this plant issue smacks of China etc. And an 800# busy? #socpharm 5/5/2010 19:19

:
T1: Many of my mom friends were irritated that the refund info wasn’t posted until well after J&J advised tossing affected meds. #socpharm 5/5/2010 19:20

:
The bigger question is this ‘If you cant trust J&J band who can you trust’ #socpharm 5/5/2010 19:21

:
RT @: @ Agree, every1 has been impressed w/ @ & they need 2 maintain that position of leadership. #socpharm 5/5/2010 19:23

:
The plant is in Pennsylvania! If you read details in the Washington Post article it’s very nasty: http://bit.ly/bHj8RA #socpharm 5/5/2010 19:23

:
And apparently the FDA spoke about the plant issues months ago. #socpharm 5/5/2010 19:24

:
True! RT @: The bigger question is this ‘If you cant trust J&J brand who can you trust’ #socpharm 5/5/2010 19:24

:
How much does everyone think this will damage the J&J reputation? #socpharm 5/5/2010 19:24

:
@ @ surprising contrast from their superb handling of the tylenol recall in the 80s, to now, esp for a #socpharm leader 5/5/2010 19:25

:
Having some tweetchat problems. #socpharm 5/5/2010 19:25

:
JnJcoom may be good but that is after the fact. The bigger issue is what happened why and what they are going to do. #socpharm 5/5/2010 19:25

:
@ And they just had practice with a similar situation a few months ago! #socpharm 5/5/2010 19:26

:
I think the damage is huge. This is a child centric country. Has or will anyone trust toys made in China? #socpharm 5/5/2010 19:27

:
@ @ @ Times like these are a test whether you truly care about your customers. #socpharm 5/5/2010 19:28

:
@ corporations are organic back then they were different today is a whole new generation of managers… managers w/FB accts #socpharm 5/5/2010 19:28

:
Interesting to me how J&J and Sanofi, considered to be SM pioneers, have stumbled in dealing with these issues of late. #socpharm 5/5/2010 19:29

:
@ if you cared about customers you dont let the FDA site your plant x number of times you step in front of it #socpharm 5/5/2010 19:30

:
T2: AstraZeneca blog monitoring database was hacked: http://bit.ly/cXlA1B. Do pts have right to be upset we’re listening? #socpharm 5/5/2010 19:31

:
@ @ agreed, they need to find a better way to capture and share institutional knowledge #socpharm 5/5/2010 19:31

:
@ Issue has been a lot of social media theory, the test will be case studies this year. No one is an expert. #socpharm 5/5/2010 19:32

:
@ it is not about being SM pioneers it’s the fact we are smarter and better connected. & angry about corporate dumb #socpharm 5/5/2010 19:32

:
@ Always good to be proactive. #socpharm 5/5/2010 19:33

:
T2 we ARE listening and are smart…pharma cant deal with that. They need a better strategy with patients and caregivers NOT SM #socpharm 5/5/2010 19:35

:
Frieda Hernandez here joining late #socpharm. Looks like some good topics as usual. 5/5/2010 19:35

:
RT @: T2: AstraZeneca blog monitoring database was hacked: http://bit.ly/cXlA1B. Do pts have right to be upset we’re listening? #socpharm 5/5/2010 19:36

:
@ Good to see you, Frieda! #socpharm 5/5/2010 19:36

:
RT @: T2 we ARE listening and are smart…pharma cant deal with that. They need a better strategy with patients and caregivers NOT SM #socpharm 5/5/2010 19:37

:
@ This blogger took offense that what he wrote was being monitored & used by pharma to craft response. Is that legit? #socpharm 5/5/2010 19:37

:
Colleen Young, also joining late. #socpharm. 5/5/2010 19:37

:
It is a strategic issue of what to do in this brave new world. These mistakes will guide changes in what patients want #socpharm 5/5/2010 19:38

:
T2: I always thought the point of a blog was getting people to pay attention to your point of view! #socpharm 5/5/2010 19:38

:
RT @: T2: I always thought the point of a blog was getting people to pay attention to your point of view! #socpharm 5/5/2010 19:38

:
Having your moral compass in the right direction is always a good SM strategy. #socpharm 5/5/2010 19:39

:
T2: Shouldn’t pharma be listening? Isn’t that what we’re asking them to do? #socpharm 5/5/2010 19:39

:
I think the question is what is a good strategy for brand enhancement with patients and caregivers, not data mining & list capture #socpharm 5/5/2010 19:39

:
Good advice! RT @: Having your moral compass in the right direction is always a good SM strategy. #socpharm 5/5/2010 19:40

:
RT @: Good advice! RT @: Having your moral compass in the right direction is always a good SM strategy. #socpharm 5/5/2010 19:40

:
RT @: I think the question is what is a good strategy for brand enhancement with patients and caregivers, not data mining & list capture #socpharm 5/5/2010 19:41

:
Amen RT @: Having your moral compass in the right direction is always a good SM strategy. #socpharm 5/5/2010 19:41

:
@ Hi Colleen, always gr8 to see you. #socpharm 5/5/2010 19:42

:
in a crisis you can only listen so much because of the degree of intensity. Pharma listening is passive. #socpharm 5/5/2010 19:42

:
Likewise Angela RT @ @ Hi Colleen, always gr8 to see you. #socpharm 5/5/2010 19:43

:
Agreed RT @: T2: Shouldn’t pharma be listening? Isn’t that what we’re asking them to do? #socpharm 5/5/2010 19:45

:
@ @ as we’ve discussed before, pharma needs to be proactive & focus on engagement not just listening #socpharm 5/5/2010 19:46

:
Listening is a PR action. They have not created a bank of credit with consumers #socpharm 5/5/2010 19:47

:
RT @ as we’ve discussed before, pharma needs to be proactive & focus on engagement not just listening #socpharm 5/5/2010 19:48

:
@ Angela, u’ve inspired me. W/ ur permission, I’m going to blog on having a moral compass in right direction driving sm #socpharm 5/5/2010 19:48

:
engagement post is harder, they should be engaged before to create that credit of good will #socpharm 5/5/2010 19:49

:
@ Absolutely, but it starts with listening then engagement. Only listening is just spying. #socpharm 5/5/2010 19:49

:
T2 IMO not at all clear that the AZ database was hackd. Managd by PR firm, may have bn posting info whr it cd B found thru search #socpharm 5/5/2010 19:50

:
@ Well, thank you! Part of core values, methinks. :) #socpharm 5/5/2010 19:50

:
@ I don’t know if listening is spying. We’re putting out this info on the Interwebs! People will read it… #socpharm 5/5/2010 19:51

:
@ to create that credit of good will they could set up a platform to let pts talk. Then listen. Then engage. #socpharm 5/5/2010 19:52

:
@ Thanks for the warm welcome. It’s mutual. #socpharm 5/5/2010 19:52

:
Part of listening is biz intelligence. Use it 2 make yourself better. No point in listening without change, even b4 engagement. #socpharm 5/5/2010 19:54

:
RT @: Part of listening is biz intelligence. Use it 2 make yourself better. No point in listening without change, even b4 engagement. #socpharm 5/5/2010 19:54

:
I agree talking is good listening is good. What happens to enhance what is heard w/o looking like ur co-opting #socpharm 5/5/2010 19:55

:
If I was the brand manager I would tweet from the plant and the workers about what we are doing to fix it #socpharm 5/5/2010 19:55

:
Connect my j&j family with yours #socpharm 5/5/2010 19:56

:
@ completely agree. That’s what I wanted to say when I used the word ‘spying’. Listen & change w/ moral compass #socpharm 5/5/2010 19:57

:
@ @ there’s nothing wrong w/ listening, it’s a step toward engagement, just keep em moving forward :) #socpharm 5/5/2010 19:57

:
Like this! RT @ If I was brand manager I would tweet from plant & the workers about what we are doing to fix it #socpharm 5/5/2010 19:57

:
Great ideas. And since this is over the counter J&J could do it. RT @: Connect my j&j family with yours #socpharm 5/5/2010 19:57

:
Wow, where did the time go? Another #socpharm flew by. Hope to tweet with you again next Wed at 8 pm EST. Let me know if u have topic ideas 5/5/2010 19:59

:
engaging is key! Listening is one thing, but CARING and giving a f*** is quite another. having phone #’s busy is not ok #socpharm 5/5/2010 19:59

:
RT @: Wow, where did the time go? Another #socpharm flew by. Hope 2 tweet with you again next Wed 8 pm EST…. #socpharm 5/5/2010 19:59

:
make those in the plant and on the line my messenger with a stake in fixing it. Put a face on the fix #socpharm 5/5/2010 19:59

:
RT @: make those in the plant and on the line my messenger with a stake in fixing it. Put a face on the fix #socpharm 5/5/2010 20:00

:
I very much agree RT @: engagement post is harder, they should be engaged before to create that credit of good will #socpharm 5/5/2010 20:00

:
@ i agree, i’d also use the @ account to reach out to concerned parties, its a missed opportunity #socpharm 5/5/2010 20:00

:
Thank U @ & everyone @ #socpharm. These discussions get better & better every week! #socpharm 5/5/2010 20:01

:
@ Thank you. I look forward to joining #socpharm again. 5/5/2010 20:01

:
RT @: engagng is key! Listenng is 1 thing, but CARING & gving a f*** is quite another. havng phn #’s busy is not ok #socpharm 5/5/2010 20:03

:
Thanks everyone, I’m off to have a margarita for Cinco de Mayo! #socpharm 5/5/2010 20:04

:
I second that! RT @: Thank U @ & everyone @ #socpharm. These discussions get better & better every week! #socpharm 5/5/2010 20:05

:
Thanks @ & everyone, yet another great #socpharm discussion…hope to see u at #bdi next week in NY 5/5/2010 20:14

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com